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ABSTRACT
Chronic kidney disease (CKD) is a condition in which damaged kidneys cannot properly filter
blood throughout the body. This results in excess fluid and waste products to remain in the
bloodstream, which can lead to other health complications if not treated. Kidney failure occurs
when an individual has 10-15% of optimal kidney functioning, resulting in toxic levels of waste
in the bloodstream. Recent literature has demonstrated that individuals receiving dialysis have
poorer cognitive functioning compared to the general population, especially in regard to
executive functioning. The purpose of the current study was to identify the executive
functioning abilities in a sample of kidney dialysis patients and to determine the feasibility of
conducting neuropsychological assessments within a dialysis clinic setting. Preliminary data
from a small sample revealed that, overall, participants did not demonstrate clinically significant
deficits in subjective or objective executive functioning abilities. However, two clinically
noteworthy profiles were analyzed. Findings also suggested that the use of the BRIEF-A and the
TMT, Parts A and B, are feasible and useful within a dialysis clinic. Clinical implications are
discussed and include the need for a behavioral health presence in dialysis clinics and routine
neuropsychological testing. Additional implications regarding the impact of cognitive
impairment on medical adherence are also discussed.
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CHAPTER 1: INTRODUCTION
Statement of the Problem
Chronic kidney disease (CKD) is a condition in which damaged kidneys cannot properly
filter blood throughout the body. This results in excess fluid and waste products to remain in the
bloodstream, which can lead to other health complications if not treated (Center for Disease
Control, 2017). According to the Center for Disease Control (CDC), it is estimated that
approximately 30 million adults in the United States are diagnosed with this disease (CDC,
2017). For those individuals living with CKD, their prognosis is generally expected to worsen
over time and, in many cases, results in kidney failure. Kidney failure occurs when an individual
has 10-15% of optimal kidney functioning, resulting in toxic levels of waste in the bloodstream
(National Kidney Foundation, 2017). Therefore, dialysis (e.g., hemodialysis, peritoneal dialysis)
is often necessary to slow the progression of the disease and improve survival (CDC, 2017).
When kidney failure is treated with dialysis, the condition is then referred to as end-stage renal
disease (ESRD).
Recent literature has examined the effect of dialysis on cognitive functioning among
individuals living with ESRD (Henry, Jamner, Choi, & Pahl, 2018). This growing body of
research has demonstrated that individuals who are treated with dialysis have poorer cognitive
functioning compared to the general population, especially in regard to attentional processes and
orientation (O’Lone et al., 2016). It is theorized that the process of undergoing dialysis directly
contributes to this diminished cognitive functioning (Henry et al., 2018). For example, the
toxicity theory of cognitive functioning suggests that the volumetric increase in fluid between
dialysis treatments leads to shifts in cognitive abilities and that the build-up of waste products
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and minerals leads to confusion and overall cognitive impairment (Henry et al., 2018).
Therefore, this theory supports the notion that dialysis patients will experience improvements in
cognitive functioning after receiving hemodialysis due to the elimination of waste throughout the
body. In contrast, the osmotic theory of cognitive functioning postulates that cognitive
functioning is influenced by the shift in fluid and solute levels from the pre-to-post dialytic state.
Therefore, cognitive functioning is believed to improve as time passes since receiving dialysis
and be more impaired during and shortly after receiving dialysis (Henry et al., 2018). In addition
to the effect of dialysis, researchers have also begun to examine the impact of comorbid medical
conditions on cognitive functioning, particularly cardiovascular disease in patients with ESRD
(Sarnak et al., 2013). For example, a growing body of literature suggests that hemodialysis
patients with comorbid cardiovascular disease have less well-developed processing speed and
executive functioning abilities compared to healthy individuals (Weiner et al., 2011). Similarly,
it was noted that lower executive functioning abilities are positively associated with
cardiovascular disease in this population (Sarnak et al., 2013).
Given this information, research is needed to further explore the level of executive
functioning that exists among patients with ESRD receiving dialysis. It is particularly important
to better understand how the direct impact of dialysis treatment impacts cognitive functioning
among these patients. Research should also aim to demonstrate that cognitive deficits in dialysis
patients may present differently (e.g., more impaired) compared to the normal aging process.
Further, research should also more closely examine how these cognitive deficits impact medical
adherence and the impact this has on health outcomes. As previous research has suggested,
decreased cognitive functioning contributes to complications in carrying out health related
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behaviors (Schnieder et al., 2015). Executive functioning, in particular, is critical in managing
these behaviors. Therefore, deficits in this area may contribute to problematic behaviors (e.g.,
decreased medication management) among dialysis patients (CDC, 2017). This body of
literature warrants continued exploration of the impact of dialysis on executive functioning skills
and how this decline relates to medical adherence among ESRD patients.
While there is burgeoning literature that examines the relationship between dialysis and
cognitive functioning, additional research is needed to better understand this relationship.
Existing studies have assessed cognitive functioning during the interdialytic interval (i.e., time
between receiving dialysis treatments; Dixit et al., 2013; Odagiri et al., 2011); however, more
literature is needed to examine patients’ level of cognitive functioning while actively receiving
dialysis treatments. Prior research has suggested that the effectiveness of interventions can be
accelerated with the use of feasibility and pilot studies (Tickle-Degnen, 2013). According to The
British National Institute for Health Research’s Evaluation, feasibility studies specifically focus
on examining whether a study “can be done” and are initially conducted to assess the research
and intervention process. As such, while there are limited studies that assess cognitive
functioning during dialysis treatments, the feasibility of administering neurocognitive
assessments to dialysis patients within a dialysis clinic is warranted.
Purpose of the Study
Existing literature has reliably demonstrated that patients living with end-stage renal
disease (ESRD) experience decreased cognitive functioning compared to the general population,
especially in executive functioning abilities (O’Lone et al., 2016). Cognitive deficits in the areas
of orientation and awareness are most commonly observed in this population. To better
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understand this relationship, recent literature has begun to study the relationship between dialysis
(i.e., hemodialysis, peritoneal dialysis) and cognitive functioning among these patients
(Neumann et al., 2017). The purpose of the current study was to identify the executive
functioning abilities in a sample of patients receiving kidney dialysis and compare their
performance to the normative sample of healthy adults. The purpose of the current study was to
also examine the feasibility of conducting neuropsychological assessments in a kidney dialysis
clinic. Specific areas that were examined included cost of materials, level of training required
for test administration, and ease of administration, among others. The current study ultimately
provides information regarding dialysis patients’ higher order thinking skills, which are
imperative for managing medications, scheduling and attending dialysis sessions, and adhering
to dietary restrictions, among other complex tasks.
Research Questions and Hypotheses
The first research question asks: Do patients receiving kidney dialysis demonstrate
executive functioning skills comparable to the normative data of healthy individuals with similar
age, sex, ethnicity, and level of education? The second research question asks: Is it feasible to
conduct neuropsychological assessments in a kidney dialysis clinic?
Hypothesis 1: It was hypothesized that patients receiving kidney dialysis would
demonstrate impaired abilities in executive functioning in comparison to normative scores as
measured by the BRIEF-A and the Trail Making Test, Part A and B (TMT, Parts A and B). This
hypothesis was supported by a growing body of literature that has demonstrated the executive
functioning deficits that exist among this population (O’Lone et al., 2016). Further, research has
also shown that these cognitive deficits are unique to receiving dialysis treatments and are not
solely due to the normal aging process. By comparing scores of executive functioning to the
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normative scores, this hypothesis aligns with previous findings (O’Lone et al., 2016). Executive
functioning was measured via the BRIEF-A and theTMT, Parts A and B, which provided both a
subjective and objective measure of executive functioning abilities. “Impaired” executive
functioning was measured via normative T-score cut-offs that are respective to both the BRIEFA and TMT, Parts A and B.
Hypothesis 2: It was hypothesized that conducting neuropsychological assessments,
especially those focusing on executive functioning abilities, would be feasible and useful within
a kidney dialysis clinic setting. This hypothesis was supported by a growing body of literature
that has examined the successful use of neuropsychological assessments among dialysis patients
(Dixit et al., 2013). Research has also suggested that dialysis patients demonstrate poorer
executive functioning abilities compared to the general population (O’Lone et al., 2016). As
such, this has been shown to lead to decreased medical adherence, as patients may experience
challenges associated with their medical regimen (e.g., medication management and dietary
restrictions; Schnieder et al., 2015). While there is a paucity of research in these areas, a better
understanding of the feasibility of conducting neuropsychological assessments among dialysis
patients is clinically warranted.
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CHAPTER 2: REVIEW OF THE LITERATURE
According to the CDC, CKD is a condition in which unhealthy kidneys are not able to
properly filter blood throughout the body. This lack of filtration causes excess fluid and waste
products to remain in the body, which can lead to other health complications, such as
cardiovascular disease (CDC, 2017). As of 2017, it was estimated that approximately 30 million
adults in the United States have been diagnosed with CKD (CDC, 2017). Demographically, this
disease occurs more frequently in women and African Americans, compared to men and
Caucasians, respectively. Individuals with CKD are also likely to develop worsening symptoms
over a period of many years. Advanced cases of this disease commonly result in kidney failure,
which is defined as having only 10-15% of optimal kidney functioning (United States Renal
System Data, 2018). Kidney failure requires either dialysis treatment or kidney transplantation
for survival. When these interventions are needed, the disease is then referred to as end-stage
renal disease (ESRD; United States Renal System Data, 2018). In 2010, it was estimated that
approximately 408,000 individuals in the United States were living on dialysis (United States
Renal System Data, 2018). Recent literature has also shown that nearly half of new dialysis
cases belong to a racial or ethnic
minority group in the United States (Burros et al., 2014). Individuals living with ESRD also
have a significantly higher likelihood of developing other health complications, compared to
healthy individuals (Helou et al., 2016). Common health complications include diabetes mellitus
and cardiovascular disease (Bahatti et al., 2016; Helou et al., 2016). Approximately half of
individuals with CKD or ESRD also live with diabetes mellitus (National Institute of Diabetes
and Digestive and Kidney Diseases, 2018). Further, it has been reported that diabetes mellitus is
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the most common cause of ESRD and is an important risk factor for cardiovascular disease
(National Institute of Diabetes and Digestive and Kidney Diseases, 2018). In addition to
comorbid health conditions, patients receiving kidney dialysis are also at a higher risk for
experiencing cognitive impairment, compared to the general population (Harciarek et al., 2016).
Recent research has demonstrated that individuals treated by hemodialysis, the most common
form of dialysis treatment among ESRD patients, performed significantly lower in areas of
orientation and attention, including skills such as processing speed and working memory
(O’Lone et al., 2016). Various theories have been postulated regarding cognitive decline in this
population. Research has specifically focused on the effect of interdialytic intervals and toxic
build-up in the body on cognitive functioning in hemodialysis patients (Henry et al., 2018). Such
theories suggest that increased toxicity levels (e.g., build-up of minerals in the body) in between
dialysis treatments contributes to cognitive impairment (Henry et al., 2018). Due to the paucity
of literature focusing on cognitive decline in kidney dialysis patients, further exploration in this
area is warranted. Specific attention should be given to the impact of increased toxicity as it
relates to specific areas of cognitive decline, such as executive functioning abilities.
Additionally, executive functioning as it relates to patients’ medical adherence should be
investigated, as research has suggested that there is an association between the effect of dialysis
treatment on decreased attention and orientation (O’Lone et al., 2016). These cognitive abilities
are essential to performing complex tasks and, therefore, may be associated with challenges
relating to medical adherence (e.g., medication management) (Schnieder et al., 2015).

EXECUTIVE FUNCTIONING AND HEMODIALYSIS

9

Chronic Kidney Disease
An individual is diagnosed with CKD if abnormalities of kidney function or structure
have been present for more than three months (The Renal Association, 2019). The medical
definition of CKD includes those individuals with marked kidney damage, including albuminuria
(i.e., protein in the urine), haematuria (i.e., blood in the urine), structural abnormalities of the
kidneys, or a history of kidney transplantation (The Renal Association, 2019). CKD is also
identified if individuals have a glomerular filtration rate (eGFR) level that is less than 60mL per
minute on two or more occasions that are 90 days apart. The value of the eGFR measures the
rate at which the kidneys filter waste products from the bloodstream in milliliters per minute, and
is calculated from a blood creatinine test, age, body size, and gender (National Kidney
Foundation, 2018). Therefore, a low eGFR indicates decreased kidney functioning, which
causes a lack of filtered waste products from exiting the body (The Renal Association, 2019).
Patients with CKD are classified depending on their level of kidney function via their eGFR, and
the presence of proteinuria, which is abnormal protein levels in the urine (The Renal Association,
2019). Thus, the eGFR and proteinuria levels directly speak to the progression, or stages, of
CKD. Stage 1 of CKD involves kidney damage with normal kidney function, with an estimated
eGFR that is greater than 90 mL with persistent proteinuria for three months or more. Stage 2
involves kidney damage with mild loss of kidney function, with an estimated eGFR that is
between 60 to 89 mL with persistent proteinuria for three months or more. Stage 3 involves mild
to severe loss of kidney function, with an estimated eGFR of 30-59 mL, and stage 4 involves
severe loss of kidney functioning with an estimated eGFR of 15-29 mL. Lastly, stage 5 involves
complete kidney failure, requiring dialysis or kidney transplantation for survival. Once the
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severity of CKD has progressed to stage 5, the individual is then diagnosed with ESRD (CDC,
2017).
According to the CDC (2017), there have been approximately 21,000 new cases of ESRD
each year since 2010. In early 2013, it was reported that 88% of affected individuals initiated
renal replacement therapy via hemodialysis, 9% initiated peritoneal dialysis, and only 2.6% of
cases received a kidney transplant (CDC, 2017). By the end of 2013, the percentage of kidney
transplantations increased to 29.2%, which caused a decrease in hemodialysis and peritoneal
dialysis rates (63.7% and 6.8%, respectively; CDC, 2017). Demographically, African Americans
are approximately 3.5 times more likely to develop ESRD compared to Caucasians in the United
States. Similarly, Hispanics are approximately 1.5 times more likely to develop ESRD compared
to non-Hispanics (CDC, 2017). Due to the chronic nature of this disease, literature has given
attention to the clinical implications of ESRD for patients receiving intensive replacement
therapies (e.g., hemodialysis). Recently, researchers have found that there is an increased rate of
anxiety and stress among individuals living with ESRD (Zamanian et al., 2018). Further results
also suggest that, due to increased psychological distress coupled with the intensity of
replacement therapy, quality of life has significantly decreased in this population (Zamanian et
al., 2018). In addition to decreased mental health, patients with ESRD are also at risk for
developing other health conditions, which has been shown to directly impact their overall
prognosis throughout treatment (Kim et al., 2011).
Health Conditions Associated with End-Stage Renal Disease
A large body of literature shows that ESRD is highly comorbid with diabetes mellitus and
cardiovascular disease (Bahatti et al., 2016; Marshall, 2014). Such health conditions are
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important to consider for patients with ESRD, as proper treatment of these health conditions may
impact their prognosis of ESRD and overall survival (Marshall, 2014). Current research has
examined the psychological and cognitive impact of these comorbid health conditions and
ESRD. For example, researchers have suggested that individuals with comorbid diabetes and
ESRD have a greater risk for experiencing anxiety and depression (Yoong et al., 2017). Further,
individuals with cardiovascular disease and ESRD have been shown to demonstrate cognitive
impairment compared to their healthy counterparts (Weiner et al., 2011). Given that diabetes
and cardiovascular disease have a large impact on the overall functioning of individuals with
ESRD, these health conditions are important to consider when treating these individuals.
Diabetes Mellitus
In 2014, 120,000 individuals in the United States and Puerto Rico began treatment for
ESRD (CDC, 2018). It was reported that diabetes was the primary cause of ESRD in
approximately 44% of these cases (CDC, 2017). Recent analysis from the U.S. Renal Data
System (2018) has shown that the incidence rates of comorbid ESRD and diabetes (ESRD-D)
has declined since 1980. However, newly diagnosed ESRD-D cases are expected to increase, as
the number of individuals with diabetes increases (CDC, 2017). Research has shown that one in
three adults with diabetes is likely to also have CKD. However, many of these individuals living
with diabetes are not aware that they are living with CKD (CDC, 2017). Further, diabetes
increases the risk of moderate to severe CKD, and is reported to be the most common cause of
ESRD (Marshall, 2014). Recent literature has also shown that patients with diabetes and ESRD
have increased rates of comorbid health conditions, such as cardiovascular disease, and
demonstrate poorer prognosis compared to patients without these comorbidities (Rhee et al.,
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2015). Further, researchers have also suggested that renal insufficiency, when coupled with
diabetes, is highly associated with major adverse cardiac events, such as acute myocardial
infarctions (Kim et al., 2011).
Cardiovascular Disease
The comorbid nature of diabetes and ESRD has been established as an important risk
factor for cardiovascular disease (Kim et al., 2011). The National Institute of Diabetes and
Digestive and Kidney Diseases (2018) reported that 69.6% of individuals who are diagnosed
with cardiovascular disease also live with chronic kidney disease. Further, cardiovascular
disease is considered the most common cause of death and accounts for approximately 53% of
deaths among patients diagnosed with ESRD (Bhatti et al., 2016). The physiological progression
of cardiovascular disease in CKD cases involves accelerated atherosclerosis and reduced left
ventricular function, due to declined renal function (Hage et al., 2009). Coronary artery disease
(CAD) is considered to be the most prevalent type of cardiovascular disease in individuals with
ESRD (Bhatti et al., 2016). Increased prevalence rates of CAD are due to the presence of other
health conditions such as diabetes, hypertension, and obesity in this population (Foley et al.,
1995). Further, atherosclerotic heart disease is considered the disease that is most frequently
linked to CKD, accounting for 40% of cases in individuals ages 66 and older (CDC, 2017). In
patients diagnosed with ESRD, acute myocardial infarctions, atherosclerotic heart disease,
congestive heart failure, and cerebrovascular accidents accounted for more than 50% of the
causes of death between 2012 and 2014 (CDC, 2017).
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Treatment Options for End-Stage Renal Disease
The available treatment options for individuals who need renal replacement therapy
include hemodialysis, peritoneal dialysis, and kidney transplantation (CDC, 2017). To date,
hemodialysis is the most common form of dialysis in the United States (National Institute of
Diabetes and Digestive and Kidney Diseases, 2019). There has also been a 3.1% increase in
kidney transplants from 2012 to 2013, resulting in a total of 17,600 transplants nation-wide
(National Institute of Diabetes and Digestive and Kidney Diseases, 2019). For patients who
undergo successful transplants, their 1-year graft survival rate (i.e., estimate of transplant
functioning) is 92% for deceased donor kidneys, and 97% for living donors. Further, there was a
significant decrease in the number of hospitalization admissions per year for patients receiving
hemodialysis in 2013 from 2005. Within this timeframe, admission rates fell from 2.1
admissions per patient year, to 1.7 admissions per patient year (Institute of Diabetes and
Digestive and Kidney Diseases, 2019).
Hemodialysis
As stated by the Institute of Diabetes and Digestive and Kidney Diseases (2019),
hemodialysis is a form of replacement treatment that filters waste products from the blood, as the
kidneys are unable to function properly. Hemodialysis also controls blood pressure, and
maintains the balance of minerals throughout the bloodstream, such as potassium, sodium, and
calcium. During hemodialysis treatment, the blood is filtered through a “dialyzer” that occurs
outside of the body. A dialyzer is oftentimes referred to as an artificial kidney, as it performs the
function of properly working kidneys. Throughout this process, the dialysis machine pumps
blood through the filter and then returns the filtered blood back into the body. While this is
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occurring, the dialyzer controls how quickly blood flows through the filter and the amount of
fluid that is removed from the body (Institute of Diabetes and Digestive and Kidney Diseases,
2019).
Peritoneal Dialysis
Peritoneal dialysis differs from hemodialysis, as it uses the lining of the abdomen,
referred to as the peritoneum, to filter blood (Institute of Diabetes and Digestive and Kidney
Diseases, 2019). Patients receiving peritoneal dialysis have a catheter surgically implanted in the
peritoneum prior to initiating treatment. During the process of peritoneal dialysis, a dialysis
solution (i.e., water with salt and various additives) flows from an external bag through the
catheter inside of the abdomen. Once the dialysis solution has fully entered the catheter, the
patient is able to ambulate. Internally, the dialysis solution absorbs waste products and toxins
from the bloodstream via the catheter. The dialysis solution and the waste products are then
drained from the abdomen back into the empty bag to be discarded (Institute of Diabetes and
Digestive and Kidney Diseases, 2019).
Kidney Transplant
A kidney transplant is similar to hemodialysis and peritoneal dialysis as it is also a
treatment, not a cure (Institute of Diabetes and Digestive and Kidney Diseases, 2019). A
properly working transplanted kidney is more effective at filtering waste products and
maintaining overall health, compared to dialysis treatments. However, certain medication is
critical after the transplantation to ensure that the immune system does not reject the new kidney
and treat it as a foreign body. Possible complications after receiving a kidney transplant include
bleeding, bladder infections, hernias, or pain or numbness within the inner thighs (Institute of
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Diabetes and Digestive and Kidney Diseases, 2019). Transplant rejection is often rare and is less
common when the kidney is received from a living donor (Institute of Diabetes and Digestive
and Kidney Diseases, 2019).
A growing body of literature has examined the effects of hemodialysis on cognitive
functioning (Dixit et al., 2013; Odagiri et al., 2011). More recent literature has investigated
executive functioning abilities, particularly in the areas of attention and processing speed in this
population (O’Lone et al., 2016). Theories have been postulated that attempt to explain the
connection between decreased cognitive functioning and its association with receiving dialysis
(Dogukon et al., 2009; Henry et al., 2018). As the number of new cases of ESRD is predicted to
increase (CDC, 2017), further investigation is needed to better understand the functional and
clinical outcomes of cognitive decline in this population.
Executive Functioning
The term executive functioning includes a number of cognitive processes, including
planning, attention, self-monitoring, self-regulation, attention, inhibition, and initiation
(Goldstein et al., 2014). Decades of research in this area has shown that these cognitive
processes are controlled by the prefrontal areas of the frontal lobe (Damasio et al., 2011). In the
1950s, researchers studying psychology and neuroscience grew interested in the specific role of
the prefrontal cortex in complex behaviors. Donald Broadbent (1953) first examined the
differences between automatic and controlled processes, which soon became referred to as the
“filter model”. Further investigation of cognitive processes led to the cognitive control model,
which expanded upon Broadbent’s model (Posner et al., 2004). Since the 1970s, 30 additional
constructs have been studied under the term “executive functioning”, making the construct
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difficult to operationally define throughout the literature (Goldstein et al., 2014). In an attempt
to identify the commonalities between each definition, Reynolds and Horton (2006) suggested
that executive functions represent the abilities to plan, to “do things”, and to perform complex
and adaptive behaviors and actions. To date, researchers have developed their own definitions of
executive functioning (McCloskey et al., 2009; Delis, 2004). While each definition is unique, a
recent review of the literature suggests that executive functioning is best represented across nine
areas of cognition, including attention, flexibility, emotion regulation, initiation, inhibitory
control, working memory, planning, organizing, and self-monitoring (Naglieri & Gooldstein,
2013).
The development and conceptualization of executive functioning models have been
supported by observations of individuals who have sustained frontal lobe damage (Goldstein et
al., 2014). Functional neuroimaging studies have provided evidence for the theory that the
prefrontal cortex is responsible for executive functioning abilities (Goldstein et al., 2014).
Specifically, research has suggested that two areas of the prefrontal cortex are important for
completing tasks that require executive functioning abilities: the anterior cingulate cortex and the
dorsolateral prefrontal cortex (Hoshi, 2001). Both of these areas of the prefrontal cortex undergo
a period of maturation that lasts into adulthood (Hoshi, 2001). Common models of executive
functioning that speak to the function of these brain structures include: the filter model
(Broadbent, 1953), cognitive control (Posner & Snyder, 1975), the cross-temporal model (Fuster,
1997), and the integrative model (Miller & Cohen, 2001). Broadbent’s model suggests that a
mental “filter” acts as a buffer that actively selects information from the environment that is used
for conscious awareness. The mental filter determines the information that is relevant or
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irrelevant, and subsequently selects the information that passes through the filter, leaving
irrelevant information to be ignored (Broadbent, 1953). In the 1970s, Posner and Snyder (1975)
expanded upon the filter model and developed the idea of cognitive control. This model focuses
on the examination of higher-level tasks, involving visual searches. Further, cognitive control is
also utilized to manage thoughts and emotion (Posner et al., 2004). Overall, cognitive control is
responsible for automatic responses and allows an individual to adapt from one situation to the
next, depending on the specific goal or task (Posner et al., 2004). Further, in the late 1990s,
Fuster (1997) developed the cross-temporal model, which synthesizes the concepts of
interference control, planning, and working memory. Fuster proposed that the purpose of
executive functioning is to organize behavior. He further explained that “temporal mediation” is
the interaction between short-term memory and the attention set (i.e., motor attention; Fuster,
2000). More recent models have built upon the cognitive control model to elucidate executive
functioning. Miller and Cohen (2001) developed the integrative model, which focuses on
activities that lead to the maintenance of goals. The integrative model is a top-down system,
suggesting that sensory and motor processing interact with each other during goal-directed
behavior (Miller & Cohen, 2001). This model also suggests that mental maps are created
between cognitive input and output, and that different neural pathways compete for the
expression of certain behavior (Miller & Cohen, 2001).
In addition to various areas of cognition (e.g., inhibitory control), executive functioning
also plays an important role in emotional information processing. Specifically, emotions are
mediated by the connection between cortical and subcortical structures (Singh & Young, 2020).
An established body of literature has shown that certain subcortical limbic structures are
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associated with various areas of emotional functioning. Such structures include the amygdala
(i.e., fear and anxiety), ventral striatum (i.e., pleasure and euphoria), insula (i.e., disgust), and the
septal region (i.e., aggression) (Kluver & Bucy, 1937). The cortical system, specifically the
orbitofrontal and dorsolateral cortices, control the modulation between the limbic system and the
prefrontal cortex. This modulatory process is known as “emotion regulation” and is responsible
for reactivity and behavior. Disruptions to these neural structures are associated with several
symptoms of behavioral dysregulation. For example, disruption to the orbitofrontal region can
lead to impulsivity, disinhibition, and irritability. Further, the dorsolateral prefrontal cortex is
associated with deficits in judgement, and the anterior cingulate is associated with emotional
flattening as well as decreased motivation and initiative (Singh & Young, 2020). Researchers
have studied the connection between executive functioning and emotion regulation and have
found that the ability to shift one’s attention and engage in cognitive flexibility is imperative for
emotion regulation. Further, it has been shown that individuals with impaired executive
functioning abilities have difficulty attending to, processing, and utilizing social or emotional
cues (Murphy et al., 2012). Clinically, decreased emotional regulation has been associated with
poor coping skills, which has been linked to the presence of psychopathology later in life (Izard
et al., 2008).
The Impact of Dialysis on Executive Functioning
Recent literature has demonstrated that individuals with CKD, especially individuals with
ESRD receiving dialysis treatment, commonly experience cognitive impairment (Dixit et al.,
2013; Harciared et al., 2016). Such cognitive impairment is associated with functional and
structural brain abnormalities (Chen et al., 2015). Research has suggested that cognitive decline
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in patients with ESRD is due to low eGFR, which leads to the accumulation of toxins in the body
and subsequently impairs brain functioning (Harciared et al., 2016). Additionally, as health
conditions (e.g., cardiovascular disease, diabetes) are frequently comorbid with ESRD, it has
been suggested that cognitive impairment may also be associated with these comorbid health
conditions (Murray, 2008). Common renal failure treatments, such as hemodialysis, have also
been shown to be associated with cognitive impairment, such as dialysis disequilibrium
syndrome, cerebral ischemia, or cerebral edema (Tuchman et al., 2013). Dialysis disequilibrium
syndrome is not well understood, however, it occurs in patients either during or immediately
following their hemodialysis treatment (Zepeda-Orozco & Quigley, 2012). Symptoms of
dialysis disequilibrium include intracranial pressure, restlessness, headache, or mental confusion
(Zepeda-Orozco & Quigley, 2012). Further, cerebral ischemia involves an insufficient amount
of blood flow to the brain, and cerebral edema involves swelling in the brain that is caused by
excessive fluid.
It is important to note that as older individuals are prone to experience relatively global
neuropsychological dysfunction, research demonstrates that older ESRD patients present with
specific impairments in psychomotor speed, attention, and executive functioning (Dixit et al.,
2013). Additional research has also addressed the potential confound of the general aging
process as the reason for cognitive decline and has provided support for the direct impact of
hemodialysis on cognitive impairment. In a review of the literature by O’Lone and colleagues
(2016), it was reliably demonstrated that individuals treated with hemodialysis had significantly
reduced cognitive abilities compared to the general population in areas of orientation and
awareness, perception, memory, verbal functions and language, construction and motor
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performance, concept formation and reasoning, and executive functioning. It was noted that
hemodialysis patients performed most poorly on tests of orientation and awareness, as well as
executive functioning in comparison to a set of normative data on healthy individuals with
similar age, sex, ethnicity, and level of education (O’Lone et al., 2016). This body of literature
provides support for the impact of hemodialysis on cognitive decline in this population and
elucidates the specific cognitive abilities that are impacted.
Additional research has also examined other areas of cognitive functioning. For example,
specific memory impairments were recently studied in ESRD patients (Jones et al., 2015).
Researchers found that ESRD patients performed poorer when the retrieval of memories required
conceptual processing rather than perceptual processing, as temporal brain regions are more
susceptible to the effects of renal disease (Jones et al., 2015). Similar research focusing on
memory found that recognition abilities are also impaired in ESRD patients (Owolabi et al.,
2016). Earlier research has also demonstrated that infantile ESRD is associated with poor
neurocognitive outcomes in areas of intellectual and executive functioning, memory, and
academic achievement during adolescence (Johnson & Warady, 2012). In terms of initiating
attention, research has shown that ESRD patients are less likely to acutely increase their state of
arousal in order to allocate attention or engage in action-preparation to assist with attention
(Harciared et al., 2016). Specific motor abilities have also been studied in this population, and it
has been suggested that ESRD patients have poorer performance in their reaction time and finger
tapping abilities (Harciarek et al., 2016; Owolabi et al., 2016). This body of literature suggests
that other areas of cognitive decline have been observed in ESRD populations compared to
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healthy control groups, including memory abilities, reaction time, cognitive processing, and
motor skills.
The Impact of the Interdialytic Interval on Cognitive Functioning
There is a growing body of literature that has examined the impact of the interdialytic
interval on cognitive functioning (Henry et al., 2018). Many studies have shown that there are
shifts or changes in cognitive functioning that are related to the length of the interdialytic interval
(Griva et al., 2003; Costa et al., 2014). For example, some studies have identified significant
improvements in cognitive functioning immediately following a single dialysis session
(Schneider et al., 2015), whereas other studies have shown significant decline in cognitive
functioning hours after a dialysis session (Costa et al., 2014). In response to these inconsistent
findings, researchers have suggested that the inherent bias of self-report measures may be
responsible (Murray, 2008). However, theories of cognitive impairment have provided further
explanations for these discrepant findings (Henry et al., 2018). For example, the toxicity theory
of cognitive functioning suggests that the increase in fluid volume that accumulates in between
each dialysis treatment leads to shifts in cognitive abilities (Dogukon et al., 2009). This theory
also purports that the build-up of waste products and minerals in the bloodstream accumulates
during the interdialytic interval leads to mild confusion and cognitive impairment (Williams et
al., 2004). Further, osmotic theory of cognitive impairment states that cognitive functioning is
influenced by the shift in fluid and solute levels from the pre-to-post dialytic state (Henry et al.,
2018). Therefore, cognitive functioning is likely to improve as time passes since receiving
dialysis and be poorer during and shortly after dialysis sessions (Henry et al., 2018). As dialysis
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disequilibrium may occur directly following a dialysis treatment, this syndrome illustrates the
osmotic theory of cognitive functioning in ESRD patients (Zepeda-Orozco & Quigley, 2012).
A growing body of literature has provided support for both the toxicity and osmotic
theories. For example, Murray and colleagues (2007) demonstrated that cognitive functioning
improved one hour after ESRD patients received hemodialysis treatment. Researchers also
found that cognitive abilities in these patients continued to improve 24 hours after receiving
hemodialysis (Patel et al., 2016). Conversely, other literature has suggested that the optimal time
to communicate with a patient is the day after receiving hemodialysis, as cognitive functioning
has declined shortly after receiving hemodialysis in ESRD patients (Schneider et al., 2015).
Researchers have further noted that important medical information and instructions are
oftentimes provided to patients the day of the dialysis treatment. Such information regarding
health status, medication use, and dietary information may be missed, as patients may not be
fully attending to the information (Schneider et al., 2015). As previous research has indicated,
attention and orientation are the most highly impacted areas of executive functioning (O’Lone et
al., 2016), and therefore may be associated with communication challenges between healthcare
providers and ESRD patients (Schnieder et al., 2015). This information is critical, as executive
functioning abilities are essential in adhering to medical instructions (Schnieder et al., 2015). As
recent literature has suggested, ESRD patients are likely to experience deficits in areas of
orientation and attention (O’Lone et al., 2016), research should examine the impact of these
cognitive deficits on medical adherence and overall health outcomes in this population. Doing
so may provide insights into the behavioral aspect of declining health in these patients (e.g.,
inconsistent medication management).
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Overall, recent literature has provided evidence for the decline in executive functioning
among patients receiving kidney dialysis (O’Lone et al., 2016). However, limited research has
focused on differentiating cognitive decline due to dialysis, as compared to the normal aging
process. Therefore, future literature should elucidate the unique impact of dialysis on cognitive
functioning, particularly executive functioning abilities in ESRD patients. Further, as theories of
cognitive functioning have been postulated to better understand the impact of dialysis treatment
on cognitive functioning (Sarnak et al., 2013), research should also aim to support these theories.
By testing these theories, research will better understand how increased toxicity and the removal
of waste products affects cognitive functioning among kidney dialysis patients. As previous
literature has suggested, this information is particularly important for healthcare providers, as
cognitive decline may directly impact medical adherence (Schnieder et al., 2015). The current
study examined the subjective and objective executive functioning abilities among dialysis
patients and postulated that decreased awareness of deficits may be associated with medical
adherence, such as medication mismanagement and poor diet, among others. As such, the
current study serves as a step toward better understanding how executive functioning abilities
relate to these areas.
Neuropsychological Assessment of Dialysis Patients
Existing literature has suggested that ESRD patients experience cognitive impairment
beyond what is expected of the normal aging process, with significant deficits in executive
functioning (O’Lone et al., 2016). Current research, however, has utilized objective testing only
between dialysis sessions or shortly after the dialysis treatment (Schnieder et al., 2015; Henry et
al., 2018), with a lack of data that assesses patients’ abilities while receiving treatment. As such,
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it is unclear as to whether ESRD patients experience greater impairment while receiving dialysis
or during the interdialytic period. This is an important question to explore, as dialysis patients
interact with and receive medical information from their healthcare providers (e.g., nephrologist,
dietician, social worker) while actively receiving dialysis. As current literature has identified
this as an area that warrants exploration (Schneider et al., 2015), further research is needed to
understand the effectiveness and feasibility of conducting neuropsychological assessments in
kidney dialysis clinics. While there is a dearth of feasibility testing within dialysis settings,
recent studies have examined the feasibility of implementing various interventions in dialysis
clinics. For example, art-based interventions (Carswell et al., 2019), exercise programs (Bennett
et al., 2020), and brief neurocognitive screeners (i.e., Montreal Cognitive Assessment (MoCA);
Agermann et al., 2017) have all been found to be feasible interventions to administer during
dialysis treatments. To date, there is an absence of literature that examines the feasibility of
conducting neuropsychological assessments specific to executive functioning during dialysis
treatment. Therefore, this area of research is warranted given the clinical implications.
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CHAPTER 3: METHOD
Research Design
An exploratory design using de-identified archival data was employed to assess the
executive functioning abilities among kidney dialysis patients. These data were taken from a
larger study that examined overall behavioral and psychological health in kidney dialysis patients
within an urban setting. The first goal of this study was to identify the executive functioning
abilities present among kidney dialysis patients and compare these abilities to available
normative data. The second goal of this study was to identify the feasibility of conducting
neuropsychological assessments within a kidney dialysis clinic.
Participants
A sample of 9 adults between the ages of 51 through 83 years participated in the study.
Overall, the sample consisted of 55.6% males (n = 5) and 44.4% females (n = 4), with an average
age of 71 (SD = 10.11). Participants were recruited from a kidney care dialysis treatment facility
in Northwest Philadelphia. The average length of time receiving dialysis was 2.22 years (SD =
1.30). Complete demographic information is presented in Table 1 and comorbid medical
conditions are presented in Table 2.
Inclusion and Exclusion Criteria
De-identified archival data that were analyzed included (a) participants who were
receiving kidney dialysis treatment at the time of data collection, (b) participants who were
receiving dialysis for a minimum of three months, and (c) participants who were at least 18 years
of age and legally able to provide informed consent prior to data collection. Data would not have
been analyzed if the participant(s): (a) was actively experiencing psychosis as reported by their
physician in the dialysis center, (b) if their physician or dialysis center staff identified that the
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patient had a history of dementia, (c) if they did not or refused to provide informed consent, and
(d) if the validity scales on the BRIEF-A were invalid and uninterpretable. However, no persons
in the database met the exclusion criteria.
Measures
Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A)
The BRIEF-A is a standardized, self-report measure for adults between the ages of 18
and 90. This measure captures a subjective view of executive function behaviors in the daily
environment. It is viewed as an ecological measure of executive functioning and describes how
executive functions impact various settings (e.g., home, work). The BRIEF-A is comprised of
75 items which includes three summary scales (i.e., Behavior Regulation, Metacognition, and
Global Executive Composite), and nine clinical scales (i.e., Inhibit, Shifting, Emotional Control,
Self-Monitoring, Initiation, Working Memory, Planning and Organization, Task Monitoring, and
Organization of Materials; Hooper et al., 2015). All items are based on three frequency response
options, including “never, sometimes, or often.” The Behavioral Regulation Index (BRI)
comprises four clinical scales, including Inhibit, Shift, Emotional Control, and Self-Monitoring.
The Metacognition Index (MI) comprises five clinical scales, including Initiate, Working
Memory, Plan/Organize, Task Monitor, and Organization of Materials. The Global Executive
Composite (GEC) is a summary score of all of the clinical scales. The BRIEF-A also includes
three validity scales, including Negativity (i.e., an unusually negative manner in responding),
Infrequency (i.e., atypical responding relative to the combined normative and clinical samples),
and Inconsistency (i.e., inconsistent responding relative to the combined normative and mixed
clinical and healthy adult samples). T scores (M = 50, SD = 10) are used to interpret executive
functioning abilities on the BRIEF-A. T scores of 65 or higher are considered to be clinically
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significant (Roth et al., 2005). The inter-rater reliability (r = .44 - .68) was moderate for this
measure in the normative sample. Internal consistency was moderate to high for the clinical
scales (⍺ = .73-.90) and was high for the index scores internal consistency (⍺ = .93-.96). Testretest reliability (r = .82 - .94) was high for the clinical scales and index scores (Roth et al.,
2005).
Trail Making Test (Part A)
The Trail Making Test, Part A (Part A) is a measure of rapid visual scanning, attention
and concentration, and cognitive processing speed (Crowe, 1998). In Part A, the participant
must trace a trail through a series of 25 numbered circles that are randomly positioned. Scoring
is based on how many seconds elapsed for participants to complete the task. Therefore, higher
scores denote a greater level of impairment (Reitan, 1958). Part A has high test re-test reliability
(r = 0.76 to 0.89) (Wagner et al., 2011), and alternative-form reliability (r = 0.79) (de Rosiers &
Kavanagh, 1987).
Trail Making Test (Part B)
The Trail Making Test, Part B (Part B) is a measure of cognitive flexibility and the ability
to rapidly shift cognitive set (Crowe, 1998; Gaudino, Geisler, & Squires, 1995). In Part B, the
participant must draw lines that connect 25 encircled numbers and letters in numerical and
alphabetical order while alternating between the numbers and letters (i.e., 1 is followed by A, A
is followed by 2, 2 is followed by B, B is followed by 3, and so on). The numbers and letters are
positioned in a random order to eliminate overlapping lines when connecting the circles. Scoring
of Part B involves recording the number of seconds that is required to complete the task.
Therefore, higher scores denote a greater level of impairment (Reitan, 1958). Part B has high
interrater reliability and alternate forms of reliability (r = 0.78 and 0.92, respectively; Charter et
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al., 1987). Part B also does not show evidence for practice effects across a time interval as long
as one year, indicating that participants do not “learn” how to take the test (Basso et al., 1999).
Demographic Questions
Participants were asked a number of demographic questions regarding their age,
ethnicity, sex, and level of education. Participants were also asked the length of time they had
been receiving dialysis. Additional items related to comorbid medical conditions were also
assessed (e.g., cardiovascular disease, diabetes mellitus).
Procedure
De-identified archival data were downloaded and obtained from a REDCap database into
SPSSv22. For the purposes of the current study, the archival data were taken from a study
approved by the investigator’s institutional review board, which examined overall behavioral and
psychological health in kidney dialysis patients (PCOM IRB approval). In the original study,
participants were asked to complete an online questionnaire that included demographic and
health related items and other measures examining behavioral and psychological health (e.g.,
depression, sleep). Participants were also asked to complete paper-based neuropsychological
tests, including the BRIEF-A and TMT, Parts A and B. All test data were compared to available
race-appropriate normative data. The BRIEF-A normative data include a normative sample of
over 1,100 adults from ethnic, racial, and educational backgrounds (Roth et al., 2005) and the
TMT, Part A and B include normative data of healthy controls of similar age, sex, ethnicity, and
level of education (Heaton norms, 2004). In total, there were nine measures on the online
questionnaire, one separate online measure, and four paper and pencil assessments. Data
collection was completed over the course of two or three sessions, depending on the participants’
availability and length of completion time. The BRIEF-A and the TMT, Parts A and B were
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administered at the end of the first session of testing, after participants completed the online
questionnaires. Additional de-identified information was collected from patient medical charts,
including medication lists, markers of diet (e.g., serum phosphorus levels), and type of dialysis.
All patient data were collected prior to the COVID-19 pandemic. For the present study, all data
were entered in a single SPSS database and the variables that were collected included all
neuropsychological test data (BRIEF-A and TMT, Parts A and B); demographic information
including age, ethnicity, length of time receiving dialysis treatment; and comorbid medical
conditions. The feasibility of conducting these assessments with a dialysis population was
examined via the “Objectives of a Feasibility Study” proposed by Orsmond and Cohn (2015).
The objectives that were analyzed included procedures and measures, intervention acceptability,
resources and study management, and preliminary evaluation of test data.
Analyses
Means and frequencies were used for demographic information, the prevalence of
comorbid medical disorders, and length of time receiving dialysis. For the BRIEF-A, T-scores of
65 or greater on the nine clinical scales (i.e., Inhibit, Shifting, Emotional Control, SelfMonitoring, Initiation, Working Memory, Planning and Organization, Task Monitoring, and
Organization of Materials) were considered clinically significant in the current sample. For the
TMT, Part A and B, the Heaton norms were used (Heaton norms, 2004). This set of normative
scores allowed for comparison of age, gender, ethnicity, and level of education in a healthy, nonclinical sample. The current study also investigated whether the sample scores were within one
standard deviation of the mean in the normative sample (M = 50; SD = 10), which were
considered clinically significant.
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CHAPTER 4: RESULTS AND DISCUSSION
Seven participants completed the BRIEF-A and nine participants completed both the
BRIEF-A and the TMT, Parts A and B. The two participants who did not complete the TMT,
Parts A and B did not consent to completing this measure during the time of data collection. The
BRIEF-A and TMT, Parts A and B were completed while each participant was receiving dialysis
treatment. Demographic variables, including age, sex, ethnicity, level of education, and length
of time receiving dialysis are presented in Table 1. The participants also reported on their
comorbid medical conditions, which are presented in Table 2. Descriptive statistics for the
BRIEF-A are presented in Table 3 and descriptive statistics for the TMT, Parts A and B are
presented in Table 4. The feasibility of conducting neuropsychological assessments within a
kidney dialysis clinic were examined and described.
Table 1
Demographic Information
Variable

Frequency (%)

Sex
Male
Female

5 (55.6)
4 (44.4)

Ethnicity
African American
White

6 (66.7)
3 (33.3)

Length of time Receiving Dialysis
Less than a year
1-2 years
2-3 years
4-5 years

3 (33.3)
3 (33.3)
2 (22.2)
1 (11.11)

Level of Education
High School
Some College
Bachelor’s Degree
Doctoral Degree

3 (33.3)
4 (44.4)
1 (11.1)
1 (11.1)
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M (SD)

Males
74
73
72
61
51

66.20 (9.98)

Females
83
82
77
69

77.75 (6.40)
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Comorbid Medical Conditions
The current sample reported various comorbid health conditions, including Type 2
diabetes mellitus, hypertension, chronic obstructive pulmonary disease, congestive heart failure,
back pain, migraines, blood clots, kidney stones, rheumatoid arthritis, asthma, glaucoma and
other vision issues, gout, and depression and anxiety. The most common comorbid medical
condition was Type 2 diabetes (44%). One third (33%) of the sample also reported a history of
blood clots and vision issues and approximately a quarter (22%) of the sample reported currently
having hypertension, chronic heart failure, kidney stones, rheumatoid arthritis, gout, and major
depression and generalized anxiety. Lastly, 11% of the sample reported having asthma, chronic
obstructive pulmonary disease, back pain, migraines, and a history of a cerebrovascular accident
(CVA). Two participants did not report a current or past history of any comorbid medical
conditions.
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Table 2
Comorbid Medical Conditions
Diagnosis
Type 2 Diabetes Mellitus
Blood Clots
Vision Issues
Hypertension
Chronic Heart Failure
Kidney Stones
Rheumatoid arthritis
Major Depression and Generalized Anxiety
Gout
Chronic Obstructive Pulmonary Disease
Asthma
Cerebrovascular Accident (CVA)
Back Pain
Migraine

Frequency (%)
4 (44%)
3 (33%)
3 (33%)
2 (22%)
2 (22%)
2 (22%)
2 (22%)
2 (22%)
2 (22%)
1 (11%)
1 (11%)
1 (11%)
1 (11%)
1 (11%)

Behavior Rating Inventory of Executive Function – Adult Version (BRIEF-A)
The BRIEF-A self-report provides a subjective measure of executive functioning and the
ability to regulate one’s environment (Hooper et al., 2015). There are nine clinical scales that
capture aspects of executive functioning, including inhibiting (Inhibit), shifting (Shift), selfmonitoring (Self-Monitor), initiating (Initiate), planning/organizing (Plan/Organize), task
monitoring (Task Monitoring), organizing materials (Organization of Materials), emotional
control (Emotional Control), and working memory (Working Memory).
The results from the clinical scales on the BRIEF-A self-report indicated that the
sample’s overall average T score for all of the clinical scales were within the sub-clinical range,
as average T scores ranged from 45.66 to 53.11. However, one participants scored in the clinical
range on the Shift (T = 69) and Self Monitor (T = 66) scales, which related to emotionalbehavioral regulation. These results indicate that 11.1% of the sample viewed themselves as
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having difficulty with aspects of their behavioral regulation skills, particularly in regard to
moving from one activity or situation to another, tolerating change, or shifting their attention
(Shift) and monitoring their emotions or behaviors (Self Monitor).
Additional results from the clinical scales showed that four participants scored in the
clinical range in regard to various cognitive abilities, including Plan/Organize (T = 66), Task
Monitor (T = 67), Organization of Materials (T = 69), and Initiate (T = 71). These results
indicate that 44% of the sample viewed themselves as having difficulty with higher order
thinking and problem-solving abilities. Specific areas of difficulty were in regard to their ability
to develop goals for future events (Plan/Organize), assess and monitor the progress of their
performance on various tasks (Task Monitor), maintain order and organization of their materials
or belongings (Organization of Materials), and begin an activity or independently generate ideas
or problem-solving strategies (Initiate).
The Global Executive Composite (GEC) index score consisted of nine clinical scales,
including Inhibit, Shift, Emotional Control, Self-Monitoring, Initiate, Working Memory,
Plan/Organize, Task Monitor, and Organization of Materials. The results of the GEC index
score produced a sub-clinical overall average score (GEC, T = 48). The sample T scores ranged
from 37 to 59, indicating that none of the participants scored in the clinical range (i.e., T scores
greater than or equal to 65) in their perception of their overall executive functioning abilities.
The Behavioral Regulation Index (BRI) comprises four clinical scales, including Inhibit,
Shift, Emotional Control, and Self-Monitoring. The BRI measures the ability to maintain
appropriate regulatory control of one’s own behavior and emotional responses (Roth et al.,
2005). The results of the BRI index score produced a sub-clinical overall average score (BRI, T
= 47). The sample T scores ranged from 37 to 67. Subjective issues with inhibiting emotional

EXECUTIVE FUNCTIONING AND HEMODIALYSIS

34

responses, modulating emotions, or monitoring social behavior was only identified for one
participant, as measured by the BRI (T = 67), indicating that the remaining eight participants did
not view these aspects of executive functioning as problematic.
The Metacognition Index (MI) comprises five clinical scales, including Initiate, Working
Memory, Plan/Organize, Task Monitor, and Organization of Materials. The MI reflects the
ability to initiate activity and general problem-solving ideas, sustain working memory, monitor
success and failure in problem-solving, and organize one’s materials and environment (Roth et
al., 2005). The results of the MI index score produced a sub-clinical overall average score (MI,
T = 49). The sample T scores ranged from 38 to 63. These results indicate that overall, the
sample did not view themselves as having difficulty with these areas of executive functioning.
Table 3
BRIEF-A Self-Report Scores
Clinical Scales

Inhibit
Shift
Emotional Control
Self-Monitoring
Initiate
Working Memory
Plan/Organize
Task Monitor
Organization of Materials

T Scores

Range of Scores

M (SD)

Minimum – Maximum

51.22 (7.87)
47.00 (9.05)
46.77 (7.45)
47.22 (11.00)
53.11 (11.65)
47.55 (6.44)
50.44 (8.51)
45.66 (9.76)
48.77 (8.71)

41 – 63
40 – 69
40 – 59
38 – 66
39 – 71
40 – 62
40 – 66
38 – 67
40 – 69

48.22 (8.07)
47.33 (9.12)
49.11 (8.43)

37 – 59
37 – 67
38 – 63

Composite Scores
Global Executive Composite (GEC)
Behavior Regulation Index (BRI)
Metacognition Index (MI)
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Trail Making Test, Part A and B
The TMT, Part A and B provides an objective measure of executive control. Part A
measures rapid visual scanning, attention and concentration, and cognitive processing speed.
Part B measures cognitive flexibility and the ability to rapidly shift cognitive set. The TMT,
Parts A and B has a mean of 50 and a standard deviation of 10 (Reitan, 1958). The results of the
TMT, Part A produced an overall score in the Below Average range (T = 44.85), with scores
ranging from the Mildly impaired range (T = 38) to the Average range (T = 51), indicating that
six out of seven participants demonstrated intact abilities in their rapid visual scanning, attention
and concentration, and cognitive processing speed abilities, in comparison to matched controls
with similar sex, age, ethnicity, and level of education (Heaton norms, 2004). The results from
the TMT, Part B produced an overall score in the Below Average range (T = 43.57), with scores
ranging from the Moderately impaired range (T = 28) to the Above Average range (T = 60).
Further, five out of seven participants demonstrated intact abilities in their cognitive flexibility
and ability to rapidly shift cognitive set, in comparison to matched controls with similar sex, age,
ethnicity, and level of education (Heaton norms, 2004).
Table 4
Trail Making Test Scores
Test
Average T Score
Part A
Part B

44.85
43.57

Participant T Scores
Part A

Qualitative Description

51
43
40

Average
Below Average
Below Average

Range of Scores
38 – 50
28 – 60
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50
47
45

Mildly Impaired
Average
Average
Average

Part B

Qualitative Description

32
44
49
28
60
45
47

Mild - Moderate
Below Average
Average
Moderate
Above Average
Average
Average
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Case Examples
Participant “David”
David is a 73-year-old African American male with 13 years of education. He has been
receiving dialysis for the past two to three years with no known medical comorbidities. On the
BRIEF-A, his BRI was elevated (T = 67) with two of the clinical scales in the clinical range
(Shift, T = 69; Self-Monitor, T = 66). These results suggest that David views himself as having
difficulty with abilities that are associated with behavioral regulation. Specific areas of
impairment that he identified involved his ability to move from one activity or situation to
another, tolerate change, or easily switch his attention (Shift). Other areas of impairment that he
identified included difficulty with monitoring the impact of his own behavior in social settings
(Self Monitor). Conversely, his scores on the TMT, Part A and B were in the Average range
(Part A = 47; Part B = 45). Taken together, these results suggest that there is a discrepancy in
David’s subjective and objective executive functioning abilities. Specifically, David’s objective
executive functioning abilities are intact, whereas he views himself as having some emotionalbehavioral dysregulation. While his BRIEF-A scores show subjective difficulty with behavioral
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regulation abilities, rather than cognitive impairments, the clinical implications of his case
warrant exploration.
Given David’s presentation, it can be hypothesized that he may experience possible
dependency on others and poor self-esteem, given his perceived lack of behavioral regulation
and intact executive functioning abilities. However, his level of dependency was not specifically
measured in the current study. However, a growing body of literature has suggested that older
adults (i.e., 65+ years old) receiving hemodialysis are dependent on other individuals to
accomplish instrumental activities of daily living (IADLs; Cook & Jassal, 2008). Common
activities that require dependency among these individuals include medication management,
meal preparation, and general housework, among others. While dependency may be medically
required for some older adults who cannot independently complete IADLs, it is important to
consider other variables that may be associated with dependency. In considering David’s case,
possible low self-esteem may relate to dependency on others, especially given his intact
objective executive functioning abilities. Despite this finding, further evaluation is needed to
understand the discrepancy between his perceived and actual functioning. Additional factors
should also be considered, including external sources that may contribute to low self-esteem,
such as negative feedback from family members. Of note, research has shown that self-esteem is
significantly lower in individuals receiving hemodialysis compared to the general population
(Rezaei & Salehi, 2016). These patients are also more likely to engage in emotion-oriented
coping styles, which involves managing the emotions associated with a stressful situation rather
than addressing the situation itself (Rezaei & Salehi, 2016; Lazarus, 1999). David’s elevated
BRI composite score suggests that he is likely to engage in emotion-oriented coping, which may
lead him to be dependent on others. While additional information is needed to more accurately
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capture the implications of David’s case, recent literature examining the increased dependency
and decreased self-esteem in this population provides clarity on the discrepancy between his
subjective and objective executive functioning abilities. An additional hypothesis that may
further explain David’s emotional dysregulation involves possible organic changes or damage to
sub-cortical structures of the limbic system (e.g., amygdala). As a result, this would not
contribute to impairments in executive functioning and would rather be associated with
emotional-behavioral dysregulation concerns, as observed in David’s profile.
Participant “John”
John is a 74-year-old Caucasian male with 16 years of education. He has been receiving
hemodialysis for the past 1-2 years and his reported medical comorbidities include congestive
heart failure and Type 2 diabetes. His scores on the BRIEF-A composite scores and clinical
scales were all within the sub-clinical range (T < 65). However, his performance on the TMT,
Part A was in the Mildly impaired range (T = 38) and his performance on the TMT, Part B was
in the Moderately impaired range (T = 28). These results suggest that John lacks a degree of
awareness or insight regarding his executive functioning abilities. Further, his clinical profile is
supported by a growing body of literature that suggests that individuals receiving hemodialysis
commonly experience deficits in orientation and awareness (O’Lone et al., 2016). This body of
literature has also shown that deficits in orientation and awareness are greater among
hemodialysis patients compared to the general population (O’Lone et al., 2016). In addition to
the impact of hemodialysis on aspects of cognitive functioning, John’s medical comorbidities
may also be negatively impacting both his impaired executive functioning abilities and level of
awareness. Established literature has shown that individuals diagnosed with Type 2 diabetes
demonstrate impaired abilities in various aspects of cognitive functioning, with two major areas
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being executive functioning and awareness (Takeuchi et al., 2011). Given this information, a
template match associated with Type 2 diabetes and hemodialysis indicated a strong match with
John’s clinical profile.
Feasibility of Administering Neuropsychological Assessments
Several variables were considered when assessing the feasibility of administering
neuropsychological assessments within a dialysis clinic setting. Orsmond and Cohn (2015)
outlined objectives that were designed to better understand the barriers to the success of
feasibility studies. The objectives that were utilized in the current study included (a) evaluation
and refinement of data collection procedures and outcome measures, (b) evaluation of
acceptability and suitability of intervention and study procedures, (c) evaluation of resources and
ability to manage and implement the study and intervention, and (d) preliminary evaluation of
participant responses to intervention.
Evaluation and Refinement of Data Collection Procedures and Outcome Measures
This first objective examined the appropriateness of the data collection procedures and
outcome measures (Orsomond & Cohn, 2015). Specific areas that were analyzed included the
participant’s ability to complete the measures (e.g., comprehension), whether the data were
complete and interpretable, appropriateness of the amount of data collection (i.e., completion
time), and whether the measures were appropriate for a dialysis population. During the data
collection process, seven participants completed the BRIEF-A and the TMT, Part A and B and
two additional participants completed only the BRIEF-A. During the administration of the
BRIEF-A, the evaluator read the items aloud to participants as a way to reduce the amount of
writing required by participants, since one arm was compromised due to the access port for
hemodialysis. The participants did not express any difficulty with understanding or
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comprehending the 75 self-report items and there were no missing data. Previous research has
not specifically examined the feasibility of self-report measures with dialysis patients while
actively receiving dialysis. However, previous studies have shown the use of self-report
measures across various constructs, including frailty and chronic pain (Chao et al., 2015), diet
(Vlaminck et al., 2001), and depression (Craven et al., 1989). Despite this existing body of
literature, there is no current research or indication from the current study that suggests that the
BRIEF-A is an inappropriate measure to use with this population.
Upon completion of the BRIEF-A, participants completed the TMT, Parts A and B. One
modification was made to the standardized administration, which involved participants using a
clipboard instead of a tabletop surface. None of the participants expressed confusion or
indicated that they did not understand the test instructions. Further, all participants completed
the assessment in full without any errors. The completed and interpretable data were compared
to a normative sample of healthy age, gender, ethnicity, and level of education-matched controls
(Heaton norms, 2004).
The appropriateness of the amount of data collection (i.e., time completion) was also
analyzed. The current study utilized a single self-report measure and a single objective measure
to assess executive functioning abilities. For the BRIEF-A, the suggested time completion is 10
to 15 minutes for individuals who complete the measure independently (Roth et al., 2005).
While the current study did not measure the number of minutes each participant required, the
average estimated completion time was within 10 to 15 minutes. For the TMT, Parts A and B,
standardized administration allows for discontinuation of the test if the participant exceeds 5
minutes for Part A and B. The results of the TMT, Part A completion time ranged from 32
seconds to 60 seconds and the TMT, Part B completion time ranged from 70 seconds to 212
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seconds. As such, the longest estimated completion time for both the BRIEF-A and TMT, Parts
A and B in the current sample was 19 minutes and 32 seconds (i.e., the highest score on the
TMT, Parts A and B in minutes; 15 minutes for the BRIEF-A) and the shortest estimated
completion time was 14 minutes and 42 seconds (i.e., the lowest score on the TMT, Parts A and
B in minutes; 10 minutes for the BRIEF-A).
In addition to the appropriateness of the amount of data collection, the appropriateness of
the use of these measures in a dialysis population was also considered. Primarily, face validity
suggested that the use of the BRIEF-A and the TMT, Part A and B is appropriate and feasible
within this population, especially considering the lack of confusion with administration
instructions, lack of errors and missing data, and short completion times. Further, a metaanalysis recently showed that, across 22 studies examining cognitive functioning abilities in this
population, the TMT, Part A was the most frequently administered test (O’Lone et al., 2016).
While it was not clear whether or not the participants in these studies completed testing while
actively receiving dialysis, the results of the current study suggest that administration of the
TMT, Parts A and B during dialysis treatments is feasible and appropriate for this population.
Evaluation of Acceptability and Suitability of Intervention and Study Procedures
The second objective examined whether the study procedures were suitable for and
acceptable to participants (Orsomond & Cohn, 2015). Specific areas that were analyzed
included retention and intervention attendance, participant engagement, and safety and
unexpected adverse events. Given the short completion time for testing, multi-session testing
was not required, indicating that retention and intervention attendance were not barriers in the
current study. Notably, a unique characteristic of testing within a dialysis clinic involves the
increased reliability of the patients being present for their treatment. As such, the patients’
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dialysis schedule can also serve as a testing schedule, if warranted, depending on the amount of
testing to be completed. Further, conducting testing in this way does not require patients to
return to the clinic on a non-treatment day. Given the increased fatigue among dialysis patients
(Horigan et al., 2012), this method is particularly efficient for both the examiner and the patients.
Participants’ levels of engagement during data collection were also analyzed. Observationally,
participants in the current sample expressed enthusiasm and engagement while interacting with
the examiner. Several participants stated that the dialysis process decreased their social
interaction which subsequently led to decreased mental health (e.g., major depression). These
personal accounts have been reflected in an existing body of literature focusing on the effects of
dialysis on overall mental health (Weisbord, 2016; Ma & Li, 2016). Therefore, this approach
provides social interaction for patients and further provides justification for the feasibility of
conducting neuropsychological assessments in a dialysis clinic setting.
Conversely, adverse events during data collection were considered and analyzed. The
most significant event that occurred in the current study involved increased noise in the dialysis
clinic. Sources of noise involved consistent dialyzer monitor tones and nurses or other patients
speaking loudly. Despite this disruption, the participants did not express any difficulty hearing
or understanding the examiner. Other factors that were considered involved the patients’ level of
fatigue, especially if testing occurred toward the middle or end of the dialysis treatment.
Potential adverse events that may arise, but were not observed in the current study, include the
patient requiring medical attention (i.e., due to complications with their dialysis) or experiencing
chronic fatigue.
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Evaluation of Resources and Ability to Manage and Implement the Study
The third objective examined whether the research team had the resources and ability to
manage the study (Orsomond & Cohn, 2015). Specific areas that were analyzed included
physical space, administrative capacity, expertise and skill, equipment, budgetary considerations,
and ethical considerations. Since the data were collected during dialysis treatments, the seating
logistics for the examiner was initially considered. Consultation with the nephrologist, social
worker, and nurses resulted in the examiner using a backless swivel chair next to the patient in
the clinic for data collection. Given the layout of the clinic, there was enough space in between
each dialysis chair for up to two examiners to sit next to a patient. Regarding administrative
capacity and study procedures, all completed hard-copy protocols were kept in a locked filing
cabinet that was located in the same building as the dialysis clinic. All demographic variables
(e.g., age, sex, level of education) were collected via an encrypted and HIPAA compliant
database (i.e., REDCap) and downloaded into a password protected SPSSv22. Each participant
was assigned a unique study identification number and all data were deidentified.
The level of training of the examiners was also considered during data collection. All
examiners were doctoral students in clinical psychology who passed the required psychological
assessment courses within the program’s curriculum. The examiners were also trained in the
standardized administration of the TMT, Parts A and B by a fourth-year doctoral candidate. The
required equipment and materials that were needed for data collection were also considered. For
both the BRIEF-A and the TMT, Parts A and B, a clipboard was required as the participants
completed the assessments in their dialysis chair. Additional materials for the TMT, Parts A and
B included a stopwatch for completion time and a pencil without an eraser.
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Regarding pricing considerations, the TMT, Parts A and B is not trademarked and is in
the public domain (i.e., can be accessed online at no cost). However, the BRIEF-A requires at
least a Level B qualification for purchase from Psychological Assessment Resources (PAR, Inc).
Level B qualification requires:
A degree from an accredited 4-year college or university in psychology, counseling,
speech-language pathology, or a closely related field plus satisfactory completion of
coursework in test interpretation, psychometrics and measurement theory, educational
statistics, or a closely related area; or license or certification from an agency that requires
appropriate training and experience in the ethical and competent use of psychological
tests. (Psychological Assessment Resources, 2021)
Purchasing options for the BRIEF-A include an Introductory Kit (i.e., BRIEF-A professional
manual, 25 self-report and informant report forms and 25 self-report and informant report
scoring summary/profile forms: $384.00), Professional Manual or e-Manual ($113.00), Self and
informant-report forms, 25-count ($91.00 each), and Self and informant-report scoring
summary/profile forms ($62.00, each).
Ethical considerations were also identified during the implementation of the study. The
most significant risk to the participant’s confidentiality involved conducting all aspects of the
study in the dialysis clinic. This represents an ethical consideration, as medical staff and other
patients are in close proximity and may have overheard a participant’s response (e.g., when
answering BRIEF-A questions). To increase participants’ comfort level, they were given the
option to complete the measure independently. However, all study participants requested that
the examiner read the questions aloud to them. They also stated that this method provided
increased social interaction while attending their dialysis treatment. Fortunately, breaches of
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confidentiality did not occur during the implementation of the current study. An additional
ethical consideration involves the possible risk of decreased self-esteem or view of their abilities
when performing the TMT, Parts A and B and the BRIEF-A. While this was not observed with
the current sample, the examiners are trained in evidenced-based interventions. As such, clinical
skills could have been utilized during data collection, if warranted.
Preliminary Evaluation of Participant Responses to Intervention
The fourth objective examined whether the intervention showed promise of being
successful with the intended population (Orsmond & Cohn, 2015). Specific areas that were
analyzed included whether the preliminary data suggested that the intervention was likely to be
successful and whether the participants or relevant others provided qualitative feedback that may
have indicated that the intervention would be successful. The results of the preliminary testing
revealed that, on average, the current sample scored within a sub-clinical range on the BRIEF-A
(i.e., T scores of 65 or below). Results also showed that on average, participants scored on the
high end of the Below Average range on the TMT, Parts A and B (Part A, T score = 44.85; Part
B, T score = 43.57; Heaton norms, 2004). While confidence intervals are not provided in the
normative scores for the TMT, Parts A and B, these results indicate that the study participants
were functioning at least within a non-impaired range. These results further suggest that possible
extraneous variables (e.g., dialyzer tones, nurses or other patients speaking) did not negatively
impact participant performance on these measures, given the lack of impaired scores. As such,
this indicates that the administration of the BRIEF-A and the TMT, Parts A and B showed
promise of being successful within a dialysis clinic setting. Lastly, the qualitative feedback that
was provided by participants further supported this conclusion. While a qualitative analysis was
not utilized in the current study, the participants commented positively on their performance
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during data collection (e.g., “I did pretty good with that!” in reference to the TMT) and indicated
that they appreciated the social interaction.
Interpretation and Implications
The current study presents the findings from an exploratory project aimed at assessing
executive functioning abilities among dialysis patients and the feasibility of conducting
neuropsychological assessments within a dialysis clinic. The first objective involved
understanding how the sample’s executive functioning abilities compared to available normative
data of healthy individuals with similar, age, sex, ethnicity, and level of education. The second
objective involved identifying and analyzing variables associated with the feasibility of
conducting the BRIEF-A and TMT, Parts A and B while participants were receiving dialysis.
Exploratory analyses demonstrated that these measures are feasible and useful to use within a
dialysis clinic setting. Preliminary quantitative results indicated that, on average, the sample did
not have elevated scores on the BRIEF-A composite scores or clinical scales. This suggests that
the sample as a whole did not view themselves as having difficulty with various thinking skills
associated with executive functioning. However, on an individual level of analysis, the data
revealed that two out of the nine participants identified difficulty with aspects of their behavioral
regulation skills, particularly in regard to moving from one activity or situation to another,
tolerating change, or shifting their attention and monitoring their emotions or behaviors. Further,
four participants identified difficulty with aspects of cognitive abilities, involving planning,
organizing, monitoring and organizing, and initiating tasks. The objective data from the TMT,
Parts A and B indicated that, on average, the sample performed in the Below Average range.
These results indicate that, overall, the participants did not demonstrate impaired executive
functioning abilities. Again, on an individual level of analysis, one out of seven participants
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demonstrated an impaired ability in visual scanning, attention and concentration, and cognitive
processing speed (Part A) and in the ability to shift cognitive set (Part B). Further, one out of the
seven participants demonstrated impaired abilities only in shifting cognitive set (Part B).
In reviewing the sample’s performance on the BRIEF-A and the TMT, Parts A and B,
two participants’ profiles were clinically significant and warranted a more in-depth analysis. The
first participant, David, was a 73-year-old African American male with 13 years of education and
no medical comorbidities. He presented with elevated perceived difficulty with aspects of
behavioral regulation, particularly in his ability to move from one activity or situation to another,
tolerate change, or easily switch his attention, as well as in his ability to monitor his performance
on various tasks. Interestingly, his performance on the TMT, Parts A and B was in the Average
range, indicating that he did not demonstrate objective impairment in executive functioning. It is
important to note that David’s perception of his executive functioning difficulties is associated
with behavioral dysregulation, rather than cognitive impairment. His profile supports the
possibility that he may be experiencing a sense of dependency on others and poor self-esteem,
especially given his perceived lack of behavioral regulation. These results further suggest the
need for behavioral health services in a dialysis clinic setting. Recent literature has shown that
integrated behavioral health for end-stage renal disease patients is associated with better clinical
outcomes, especially for those patients with comorbid medical issues (e.g., diabetes, congestive
heart failure; Datta & Ogbeide, 2019). Furthermore, mental health professionals can also
provide evidence-based interventions to reduce maladaptive cognitions and behaviors, such as
low self-esteem and dependency on others, which can lead to altered self-perception, as observed
in David’s case.
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The second participant, John, also presented with a clinically significant profile. He is a
74-year-old Caucasian male with 16 years of education. His medical comorbidities include
congestive heart failure and Type 2 diabetes. He presented with sub-clinical scores on the
BRIEF-A, indicating that he does not view himself as having difficulty with various thinking
skills associated with executive functioning. Interestingly, his performance on the TMT, Part A
was Mildly impaired and his performance on Part B was Moderately impaired. John’s clinical
profile indicates that he lacks a degree of awareness regarding his executive functioning abilities.
This finding aligns with a growing body of literature that shows that orientation and awareness
are significantly, negatively impacted among dialysis populations compared to healthy adults
(O’Lone et al., 2016). John’s clinical profile suggests the need for the presence of mental health
professionals in dialysis clinics and routine neurocognitive testing for dialysis patients given the
significant implications of decreased executive functioning abilities and impairment in
orientation and awareness. These implications may include medication non-adherence, poor
diet, missed dialysis appointments, and noncompliance with other medical instructions or
recommendations (Schnieder et al., 2015). As such, mental health providers can implement
effective interventions to promote patients’ awareness of maladaptive behaviors, including
activity scheduling, visual cues, and alarm clocks which may ultimately promote better health
outcomes (Farragher & Jassal, 201
Strengths
There are several strengths of the current study noted. First, and most importantly, the
study provided further insight into the executive functioning abilities among patients receiving
kidney dialysis. This study also provided specific information regarding two participants in the
current sample that presented with clinically relevant profiles. These two participants were in
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contrast to one another yet provided an anecdotal view into their overall unique levels of
functioning. To that end, the information that was gleaned from their specific cases allowed for
clinical recommendations, such as the need for mental health providers within a dialysis clinic
setting. Another significant strength of the current study involved providing clinically relevant
information for physicians and psychologists treating this population. Specifically, one piece of
datum from the sample aligned with existing literature showing that dialysis patients experience
significant impairment in orientation and awareness (O’Lone et al., 2016). The current study
also speaks to the importance of mental health treatment among this population, and how mental
health providers can assess for cognitive decline among this population. Further, this
information may help to inform treatment, and may also assist in problem-solving during
problematic situations (e.g., missed appointments, decreased medication adherence). Additional
strengths involved the use of subjective and objective measures of executive functioning, as well
as available normative data based on age, sex, ethnicity, and level of education. Lastly, the
current study analyzed various factors that support the feasibility of conducting
neuropsychological assessments within a dialysis clinic setting.
Limitations
The current study included several limitations. The most significant limitation was that
data collection began prior to the COVID-19 pandemic and was ultimately interrupted as a
result. As such, the current study involved a limited sample size of individuals within a single
urban area. It is also important to consider that, given this limited sample within a single
geographic area, the subjective views of executive functioning may have reflected various
challenges that are relative to the environment of the participant. Given the limited sample size,
an exploratory design was utilized, and no statistical analyses were conducted. Therefore,
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specific conclusions regarding the relationships between certain groups (e.g., TMT, Parts A and
B scores and BRIEF-A scores) were not possible, and the direct impact of kidney dialysis on
executive functioning abilities was not studied. Additionally, the current study did not utilize the
informant-report version of the BRIEF-A. Including this measure would have provided a
multifaceted view of participants’ executive functioning abilities and would have contributed to
the overall richness of the data. Additionally, since the items on the BRIEF-A self-report were
read aloud to the participants, the possibility of response bias exists within the data. Other
limitations involved possible extraneous variables, including increased noise within the dialysis
clinic that may have negatively impacted the sample’s performance on the TMT, Parts A and B,
despite overall intact scores. While fatigue did not appear to negatively impact the participants’
performances on the measures, it was not specifically measured. Therefore, it is unclear if
fatigue negatively impacted the participants’ performances on testing. Further, a quantitative
measure was not used to more specifically study the feasibility of conducting neuropsychological
assessments in this setting.
Future Directions
Future research should aim to examine the direct impact of kidney dialysis on executive
functioning. As the current study was exploratory in nature, inferences from causal relationships
were not possible. Therefore, additional research should employ an experimental design that
examines the differences between kidney dialysis patients and a healthy control group. Specific
areas to consider involve comparing objective abilities among various demographic variables
(e.g., sex, age groups, level of education). Other experimental designs should examine the length
of time receiving dialysis on executive functioning abilities, as well as the severity level of renal
disease on executive functioning abilities. An additional variable that should be quantitatively
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measured involves adherence to medical instructions or recommendations and how it relates to
executive functioning abilities, such as medication adherence, dialysis treatment attendance, and
diet, among others. Further, research should also incorporate various measures of executive
functioning to gain a more reliable and robust understanding of these abilities among this
population. Similarly, future research should also consider other areas of cognitive functioning
among this population, such as immediate and delayed visual and auditory memory, perceptual
reasoning, and processing speed. Regarding the clinical use of neuropsychological assessments
within this setting, additional recommendations have been derived from the current study. Such
recommendations involve providing psychoeducation to the medical staff in the dialysis clinic.
This would allow for a multi-disciplinary, team-based approach and will ultimately educate the
medical staff about the importance of assessing cognitive functioning among this population.
Further, the use of verbally administered neuropsychological assessments, rather than paper-andpencil-based assessments, is also highly recommended. As dialysis patients may experience
limited mobility with the use of their upper extremities due to their access port, this is a factor
that clinicians should be aware of and sensitive towards. To that end, several neuropsychological
assessments could be considered, including the California Verbal Learning Test, 2nd edition
(CVLT-II), Mini Mental Status Exam (MMSE), Controlled Oral Word Association Test
(COWAT), and Stroop Test, among others. These measures will also allow for the assessment of
a wide range of cognitive abilities that should be explored within this population. Lastly, while
data were collected prior to the COVID-19 pandemic, future administration of
neuropsychological assessments will require the use of personal protective equipment (PPE).
Common PPE includes a face mask, surgical gloves, and a face shield. For administration of the
TMT, Parts A and B specifically, there are limitations with the use of PPE that may impact
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standardized administration. Such limitations include visual obstructions if the face mask
develops condensation and slowed writing speed while wearing surgical gloves.
Conclusion
The exploratory nature of the current study provides insight into the subjective and
objective executive functioning abilities among a small sample of dialysis patients within
Northwest Philadelphia. Despite the lack of an exploratory design, the current study examined
two participants in particular who presented with clinically noteworthy profiles. Clinical
recommendations were drawn from the two cases, involving the need for routine psychological
testing and behavioral health services within this setting. Additionally, the current study
examined the feasibility and usefulness of conducting neuropsychological assessments within a
dialysis clinic setting. Various areas were addressed, including data collection procedures and
outcome measures, the acceptability and suitability of intervention and study procedures,
evaluation of resources and ability to manage and implement the study, and preliminary
evaluation of participant responses and data. This in-depth analysis suggested that the
administration of the BRIEF-A and the TMT, Parts A and B are, in fact, feasible to use within a
dialysis clinic setting. The implications of this study, particularly involving the feasibility and
usefulness of neuropsychological testing, are clinically relevant for healthcare professionals
working with this population. Such implications involve being able to identify potential deficits
in executive functioning abilities and how these deficits may negatively impact aspects of
medical adherence, such as medication management. Lastly, the current study also provides
practical recommendations to help guide future clinical uses of neuropsychological assessments
within this setting.
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